论文部分内容阅读
目的:探讨替米沙坦联合洛伐他汀治疗高血压合并脑梗死的临床效果。方法:选取高血压合并脑梗死患者108例,随机分为对照组和观察组,每组54例。对照组患者使用替米沙坦进行治疗,观察组患者使用替米沙坦联合洛伐他汀的方式进行治疗,对比两组患者治疗的总有效率,并观察两组患者对治疗的满意程度和治疗前后血压的变化。结果:治疗后,两组患者血压均比治疗前好转,但是观察组患者的恢复速度比对照组快,治疗效果更明显,差异有统计学意义(P<0.05)。在满意度评分方面,观察组的满意程度明显高于对照组,差异有统计学意义(P<0.05);在治疗总有效率方面,观察组患者治疗总有效率为98.15%明显高于对照组患者的85.19%,差异有统计学意义(P<0.05)。结论:替米沙坦联合洛伐他汀治疗高血压合并脑梗死比单纯使用替米沙坦的效果更好,能够提高治疗的总有效率和患者满意度。
Objective: To investigate the clinical effect of telmisartan and lovastatin in treating hypertension complicated with cerebral infarction. Methods: A total of 108 hypertensive patients with cerebral infarction were randomly divided into control group and observation group, with 54 cases in each group. The patients in the control group were treated with telmisartan. The patients in the observation group were treated with telmisartan and lovastatin. The total effective rate of the two groups was compared. The satisfaction and treatment of the two groups were observed Changes in blood pressure before and after. Results: After treatment, the blood pressure of both groups improved more than before treatment, but the recovery rate of the observation group was faster than that of the control group, and the treatment effect was more obvious. The difference was statistically significant (P <0.05). In the satisfaction score, the satisfaction of the observation group was significantly higher than that of the control group, the difference was statistically significant (P <0.05); in the total effective rate, the total effective rate was 98.15% in the observation group was significantly higher than the control group 85.19% of patients, the difference was statistically significant (P <0.05). CONCLUSION: Telmisartan combined with lovastatin is more effective than telmisartan in the treatment of hypertension complicated with cerebral infarction, which can improve the total effective rate of treatment and patient satisfaction.